EPS for Summit Therapeutics PLC (ADR) (SMMT) Expected At $1.38; Pinnacle Financial Partners Lowered United Parcel Service (UPS) Position By $388,284

September 6, 2017 - By test

Pinnacle Financial Partners Inc decreased United Parcel Service Inc (UPS) stake by 63.68% reported in 2016Q4 SEC filing. Pinnacle Financial Partners Inc sold 3,406 shares as United Parcel Service Inc (UPS)’s stock declined 3.26%. The Pinnacle Financial Partners Inc holds 1,943 shares with $223,000 value, down from 5,349 last quarter. United Parcel Service Inc now has $98.65B valuation. The stock decreased 0.01% or $0.01 on September 5, reaching $113.92. About shares traded. United Parcel Service, Inc. (NYSE:UPS) has risen 2.10% since September 6, 2016 and is uptrending. It has underperformed by 14.60% the S&P500.

Analysts expect Summit Therapeutics PLC (ADR) (NASDAQ:SMMT) to report $1.38 EPS on September, 14.They anticipate $2.03 EPS change or 312.31% from last quarter’s $-0.65 EPS. SMMT’s profit would be $17.09M giving it 2.40 P/E if the $1.38 EPS is correct. After having $-0.50 EPS previously, Summit Therapeutics PLC (ADR)’s analysts see -376.00% EPS growth. It closed at $13.26 lastly. It is down 33.22% since September 6, 2016 and is uptrending. It has outperformed by 16.52% the S&P500.

Pinnacle Financial Partners Inc increased Alps Etf Tr (AMLP) stake by 57,859 shares to 281,525 valued at $3.55 million in 2016Q4. It also upped Intl Paper Co (NYSE:IP) stake by 17,666 shares and now owns 37,089 shares. Celgene Corp (NASDAQ:CELG) was raised too.

Among 18 analysts covering United Parcel Service (NYSE:UPS), 6 have Buy rating, 1 Sell and 11 Hold. Therefore 33% are positive. United Parcel Service has $12600 highest and $88 lowest target. $113’s average target is -0.81% below currents $113.92 stock price. United Parcel Service had 35 analyst reports since July 29, 2015 according to SRatingsIntel. Loop Capital initiated United Parcel Service, Inc. (NYSE:UPS) rating on Tuesday, December 20. Loop Capital has “Hold” rating and $124 target. JP Morgan initiated the shares of UPS in report on Tuesday, December 13 with “Neutral” rating. As per Tuesday, August 8, the company rating was upgraded by Citigroup. On Tuesday, August 25 the stock rating was upgraded by Zacks to “Hold”. The company was reinitiated on Tuesday, February 23 by Morgan Stanley. Cowen & Co maintained United Parcel Service, Inc. (NYSE:UPS) on Monday, July 17 with “Hold” rating. On Wednesday, February 1 the stock rating was downgraded by BMO Capital Markets to “Market Perform”. The company was maintained on Wednesday, February 3 by Oppenheimer. Robert W. Baird maintained United Parcel Service, Inc. (NYSE:UPS) rating on Thursday, August 24. Robert W. Baird has “Hold” rating and $118.0 target. The rating was maintained by BMO Capital Markets with “Hold” on Wednesday, July 5.

Investors sentiment increased to 1.05 in Q4 2016. Its up 0.07, from 0.98 in 2016Q3. It is positive, as 49 investors sold UPS shares while 433 reduced holdings. 108 funds opened positions while 392 raised stakes. 457.21 million shares or 1.93% more from 448.58 million shares in 2016Q3 were reported. Deprince Race & Zollo holds 0.96% or 426,623 shares. Schulhoff And Com accumulated 16,573 shares or 1.17% of the stock. Ameriprise Finance Inc invested in 5.48 million shares. Robeco Institutional Asset Mngmt Bv owns 439,227 shares or 0.39% of their US portfolio. Paradigm Asset Mngmt Company Llc holds 0% or 38,028 shares in its portfolio. Butensky & Cohen Security Inc stated it has 0% in United Parcel Service, Inc. (NYSE:UPS). Meyer Handelman Com reported 0.14% in United Parcel Service, Inc. (NYSE:UPS). Crawford Counsel holds 2.66% or 641,178 shares. Nationwide Fund Advsr has 192,065 shares. Pictet Asset Ltd reported 437,226 shares. Franklin Street Advisors Inc Nc owns 3,007 shares. Qs Investors Ltd Co invested 0.04% in United Parcel Service, Inc. (NYSE:UPS). Richard Bernstein Advisors Ltd has invested 0.49% in United Parcel Service, Inc. (NYSE:UPS). Moreover, Comerica Bank & Trust has 0.2% invested in United Parcel Service, Inc. (NYSE:UPS). Loomis Sayles & Ltd Partnership reported 5.52 million shares.

Since June 5, 2017, it had 0 insider purchases, and 1 insider sale for $214,980 activity. 2,000 shares were sold by Gutmann Kathleen M., worth $214,980 on Monday, June 5.

Among 6 analysts covering Summit Therapeutic (NASDAQ:SMMT), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Summit Therapeutic had 8 analyst reports since August 19, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, July 6 by H.C. Wainwright. The company was downgraded on Tuesday, September 1 by Zacks. Janney Capital initiated Summit Therapeutics PLC (ADR) (NASDAQ:SMMT) on Tuesday, June 21 with “Buy” rating. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, November 16 report. Oppenheimer maintained Summit Therapeutics PLC (ADR) (NASDAQ:SMMT) on Wednesday, August 19 with “Buy” rating. The stock has “Buy” rating by Oppenheimer on Thursday, June 22. H.C. Wainwright initiated Summit Therapeutics PLC (ADR) (NASDAQ:SMMT) on Friday, September 16 with “Buy” rating. On Thursday, June 15 the stock rating was maintained by Canaccord Genuity with “Buy”.

Summit Therapeutics plc is a biopharmaceutical company, which is engaged in drug development. The company has market cap of $164.23 million. The Firm is focused on the discovery, development and commercialization of medicines for indications for which there are no existing or only inadequate therapies. It currently has negative earnings. It is conducting clinical programs focused on the genetic disease Duchenne muscular dystrophy and the infectious disease Clostridium difficile infection (CDI).